To evaluate the therapeutic response to uterine artery embolization in 30 patients with leiomyoma using the microspheres Embosoft (Embosoft® - Scitech Medical).
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
32
Uterine Embolization with PVA Microspheres
Certa Centro de Referência em Tratamentos Avançados
São Paulo, São Paulo, Brazil
Uterine Volume Reduction
Uterine Volume Reduction measured by MRI
Time frame: 6 months
Fibroid Reduction
Fibroid Reduction measured by MRI
Time frame: 6 months
Quality of Life Improvement
Quality of Life Improvement measured by UFS-QOL
Time frame: 6 months
Ovarian Function
Ovarian Function measured by Anti-Mullerian Hormon dosage pre and post-procedure
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.